Home > Insider Trading > Filing (0001209191-21-051299)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1832038	Adagio Therapeutics Inc.	ADGI	Biological Products, (No Disgnostic Substances) (2836)	851403134

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1875614	Ajay Royan	C/O Adagio Therapeutics, Inc. 303 Wyman Street, Suite 300 Waltham MA 02451		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-08-10	9,244,580	$0.00	9,244,580	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2021-08-10	1,997,000	$17.00	11,241,580	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2021-08-10	1,250,000	$0.00	6,250,000	$0.00
Common Stock	Series B Preferred Stock	Disposition	2021-08-10	176,304	$0.00	881,520	$0.00
Common Stock	Series C Preferred Stock	Disposition	2021-08-10	422,612	$0.00	2,113,060	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into 5 shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date.
These shares are held of record by Mithril II LP ("II LP"). Mithril II UGP LLC ("UGP II") is the general partner of Mithril II GP LP ("GP II") and GP II is the general partner of II LP. The Reporting Person, a member of the Issuer's board of directors, is the sole managing member of UGP II and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by II LP. The Reporting Person is one of two members of the investment committee of GP II. The investment committee makes all investment decisions with respect to shares held by II LP and may be deemed to have shared voting, investment and dispositive power with respect to such shares. The Reporting Person disclaims beneficial ownership of the shares held by II LP, except to the extent of the Reporting Person's pecuniary interest therein, if any.